Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
Domenico Corrado1, Alessandro Zorzi1, Alberto Cipriani1
1Department of Cardiac, Thoracic and Vascular Sciences and Public Health University of Padova Italy.
Insights
The 2020 International criteria for arrhythmogenic cardiomyopathy (ACM) enhance diagnosis by including left ventricular involvement and cardiac magnetic resonance imaging. These updated guidelines improve detection of the full spectrum of ACM phenotypes.
Area of Science:
- Cardiology
- Medical Diagnostics
- Cardiac Imaging
Background:
- Previous arrhythmogenic cardiomyopathy (ACM) diagnostic criteria (1994, 2010) accurately identified right ventricular disease but missed left-sided variants.
- These earlier criteria did not incorporate cardiac magnetic resonance (CMR) late-gadolinium enhancement (LGE) findings, crucial for fibrosis detection.
Purpose of the Study:
- To review the evolution of ACM diagnostic criteria.
- To detail the advancements introduced by the 2020 International criteria (Padua criteria).
- To highlight the improved diagnostic capabilities for the expanding ACM phenotypic spectrum.
Main Methods:
- Review of historical (1994, 2010) and current (2020) International Task Force criteria for ACM diagnosis.
- Emphasis on the role of cardiac magnetic resonance (CMR) with late-gadolinium enhancement (LGE) in the 2020 criteria.
- Inclusion of new criteria for left ventricular (LV) abnormalities and arrhythmias.
Main Results:
- The 2020 criteria significantly improve the diagnosis of arrhythmogenic biventricular and left ventricular cardiomyopathy.
- CMR with LGE is now mandatory for characterizing ACM phenotypes and excluding other conditions.
- New ECG and arrhythmia criteria enhance the identification of left-sided ACM variants.
Conclusions:
- The 2020 International criteria represent a major advancement in diagnosing the full spectrum of arrhythmogenic cardiomyopathy.
- Cardiac magnetic resonance imaging is indispensable for accurate ACM diagnosis under the new guidelines.
- These criteria enhance the ability to detect and characterize both right and left ventricular involvement in ACM.
Abstract:
Criteria for diagnosis of arrhythmogenic cardiomyopathy (ACM) were first proposed in 1994 and revised in 2010 by a Task Force. Although the Task Force criteria demonstrated a good accuracy for diagnosis of the original right ventricular phenotype (arrhythmogenic right ventricular cardiomyopathy), they lacked sensitivity for identification of the expanding phenotypic spectrum of ACM, which includes left-sided variants and did not incorporate late-gadolinium enhancement findings by cardiac magnetic resonance. The 2020 International criteria ("Padua criteria") have been developed by International experts with the aim to improve the diagnosis of ACM by providing new criteria for the diagnosis of left ventricular phenotypic features. The key upgrade was the incorporation of tissue characterization findings by cardiac magnetic resonance for noninvasive detection of late-gadolinium enhancement/myocardial fibrosis that are determinants for characterization of arrhythmogenic biventricular and left ventricular cardiomyopathy. The 2020 International criteria are heavily dependent on cardiac magnetic resonance, which has become mandatory to characterize the ACM phenotype and to exclude other diagnoses. New criteria regarding left ventricular depolarization and repolarization ECG abnormalities and ventricular arrhythmias of left ventricular origin were also provided. This article reviews the evolving approach to diagnosis of ACM, going back to the 1994 and 2010 International Task Force criteria and then grapple with the modern 2020 International criteria.
More Related Videos
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias


